Clinical trial
Docetaxel and Irinotecan in Treating Patients With Advanced Cancer of the…
NCT00004235 · Alliance for Clinical Trials in Oncology, Other · Completed
Key facts
| NCT number | NCT00004235 |
|---|---|
| Title | Docetaxel and Irinotecan in Treating Patients With Advanced Cancer of the Esophagus or Stomach |
| Official title | A Phase II Study of Taxotere and Irinotecan (CPT-11) in Patients With Advanced Adenocarcinoma of the Lower Esophagus, Esophagogastric Junction, and Gastric Cardia |
| Lead sponsor | Alliance for Clinical Trials in Oncology, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Esophageal Cancer, Gastric Cancer |
| Intervention type | Drug |
| Interventions | docetaxel, irinotecan hydrochloride |
| Enrollment | 47 |
| Start date | Jan 1, 2000 |
| Primary completion | Aug 1, 2004 |
| Completion | Aug 1, 2004 |
| First posted | Mar 3, 2004 |
| Last update posted | Jul 14, 2016 |
| Countries | Canada, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: